Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
SFDA · 42 medicines · Historical list
CBG-MEB · 33 medicines
FDA · 31 medicines
PHARMAC · 25 medicines
AEMPS · 20 medicines
AIFA · 15 medicines
HSA · 14 medicines
MS · 9 medicines · Historical list
HALMED · 5 medicines
ALIMS · 5 medicines
TFDA · 3 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
25 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| SalAir | New Zealand | Aerosol inhaler, 100 mcg per dose | Funded | ||
| SalAir | New Zealand | Aerosol inhaler, 100 mcg per dose CFC free | Funded | ||
| CombiprasalCombination | New Zealand | Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml ampoule | Funded | ||
| CombiprasalCombination | New Zealand | Nebuliser soln 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml ampoule | Funded | ||
| AnyCombination | New Zealand | Aerosol inhaler 100 mcg with ipratropium bromide 20 mcg per dose | Funded | ||
| Any | New Zealand | Inj 500 mcg per ml, 1 ml ampoule | Funded | ||
| Any | New Zealand | Inj 1 mg per ml, 5 ml ampoule | Funded | ||
| Asthalin | New Zealand | Nebuliser soln, 1 mg per ml, 2.5 ml ampoule | Funded | ||
| Asthalin | New Zealand | Nebuliser soln 2 mg per ml, 2.5 ml ampoule | Funded | ||
| Asthalin | New Zealand | Nebuliser soln, 2 mg per ml, 2.5 ml ampoule | Funded | ||
| Asthalin | New Zealand | Nebuliser soln 1 mg per ml, 2.5 ml ampoule | Funded | ||
| CiplaCombination | New Zealand | Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 3 ml vial | Funded | ||
| CiplaCombination | New Zealand | Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 3.0 ml vial | Funded | ||
| DuolinCombination | New Zealand | Nebuliser soln 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml ampoule | Funded | ||
| DuolinCombination | New Zealand | Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml ampoule | Funded | ||
| Duolin HFACombination | New Zealand | Aerosol inhaler, 100 mcg with ipratropium bromide, 20 mcg per dose CFC-free | Funded | ||
| UK Cipla | New Zealand | Nebuliser soln, 2 mg per ml, 2.5 ml ampoule | Funded | ||
| UK Cipla | New Zealand | Nebuliser soln 2 mg per ml, 2.5 ml ampoule | Funded | ||
| UK Cipla | New Zealand | Nebuliser soln, 1 mg per ml, 2.5 ml ampoule | Funded | ||
| UK Cipla | New Zealand | Nebuliser soln 1 mg per ml, 2.5 ml ampoule | Funded | ||
| Ventolin | New Zealand | Aerosol inhaler, 100 mcg per dose CFC free | Funded | ||
| Ventolin | New Zealand | Oral liq 400 mcg per ml | Funded | ||
| Ventolin | New Zealand | Inj 500 mcg per ml, 1 ml | Funded | ||
| Ventolin | New Zealand | Aerosol inhaler, 100 mcg per dose | Funded | ||
| Ventolin | New Zealand | Infusion 1 mg per ml, 5 ml | Funded |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
